320 related articles for article (PubMed ID: 33859746)
1. Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function.
Lu X; Zhang J; Liu H; Ma W; Yu L; Tan X; Wang S; Ren F; Li X; Li X
Theranostics; 2021; 11(11):5267-5278. PubMed ID: 33859746
[No Abstract] [Full Text] [Related]
2. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
[TBL] [Abstract][Full Text] [Related]
3. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
[No Abstract] [Full Text] [Related]
4. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
Marsboom G; Toth PT; Ryan JJ; Hong Z; Wu X; Fang YH; Thenappan T; Piao L; Zhang HJ; Pogoriler J; Chen Y; Morrow E; Weir EK; Rehman J; Archer SL
Circ Res; 2012 May; 110(11):1484-97. PubMed ID: 22511751
[TBL] [Abstract][Full Text] [Related]
5. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-Like Peptide-1 Receptor Agonist Attenuates Autophagy to Ameliorate Pulmonary Arterial Hypertension through Drp1/NOX- and Atg-5/Atg-7/Beclin-1/LC3β Pathways.
Wu YC; Wang WT; Lee SS; Kuo YR; Wang YC; Yen SJ; Lee MY; Yeh JL
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336911
[TBL] [Abstract][Full Text] [Related]
7. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
[No Abstract] [Full Text] [Related]
8. PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
Kovacs L; Cao Y; Han W; Meadows L; Kovacs-Kasa A; Kondrikov D; Verin AD; Barman SA; Dong Z; Huo Y; Su Y
Am J Respir Crit Care Med; 2019 Sep; 200(5):617-627. PubMed ID: 30817168
[No Abstract] [Full Text] [Related]
9. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.
Zhuan B; Wang X; Wang MD; Li ZC; Yuan Q; Xie J; Yang Z
Aging (Albany NY); 2020 Nov; 12(23):23684-23697. PubMed ID: 33221740
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
[TBL] [Abstract][Full Text] [Related]
12. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
Luo S; Kan J; Zhang J; Ye P; Wang D; Jiang X; Li M; Zhu L; Gu Y
J Cardiovasc Pharmacol; 2021 Aug; 78(2):253-262. PubMed ID: 34554677
[TBL] [Abstract][Full Text] [Related]
13. Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90α axis.
Liu M; He H; Fan F; Qiu L; Zheng F; Guan Y; Yang G; Chen L
J Mol Cell Cardiol; 2023 Aug; 181():15-30. PubMed ID: 37244057
[TBL] [Abstract][Full Text] [Related]
14. 3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism.
Guo Y; Liu X; Zhang Y; Qiu H; Ouyang F; He Y
Life Sci; 2020 Sep; 256():118009. PubMed ID: 32603819
[TBL] [Abstract][Full Text] [Related]
15. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z
J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
[No Abstract] [Full Text] [Related]
17. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
[TBL] [Abstract][Full Text] [Related]
18. Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation.
Tang L; Cai Q; Wang X; Li X; Li X; Chen L; Yang Y
Clin Exp Hypertens; 2023 Dec; 45(1):2278205. PubMed ID: 37970663
[TBL] [Abstract][Full Text] [Related]
19. Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 Signaling.
Li T; Li S; Feng Y; Zeng X; Dong S; Li J; Zha L; Luo H; Zhao L; Liu B; Ou Z; Lin W; Zhang M; Li S; Jiang Q; Qi Q; Xu Q; Yu Z
Oxid Med Cell Longev; 2020; 2020():6973636. PubMed ID: 32617141
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension.
Nogueira-Ferreira R; Ferreira-Pinto MJ; Silva AF; Vitorino R; Justino J; Costa R; Moreira-Gonçalves D; Quignard JF; Ducret T; Savineau JP; Leite-Moreira AF; Ferreira R; Henriques-Coelho T
J Cell Physiol; 2017 Nov; 232(11):3128-3138. PubMed ID: 28036116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
